Cargando…

A Study of Q-switched Nd:YAG Laser versus Itraconazole in Management of Onychomycosis

CONTEXT: Onychomycosis (OM) accounts for 20%–40% of all nail disorders. Slow growth of nails, resistance to antifungal drugs, their side effects, and drug interactions limit treatment options. Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser is approved for nail clearance of OM, how...

Descripción completa

Detalles Bibliográficos
Autores principales: Kandpal, Renu, Arora, Sandeep, Arora, Divya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149989/
https://www.ncbi.nlm.nih.gov/pubmed/34084015
http://dx.doi.org/10.4103/JCAS.JCAS_29_20
_version_ 1783698067680133120
author Kandpal, Renu
Arora, Sandeep
Arora, Divya
author_facet Kandpal, Renu
Arora, Sandeep
Arora, Divya
author_sort Kandpal, Renu
collection PubMed
description CONTEXT: Onychomycosis (OM) accounts for 20%–40% of all nail disorders. Slow growth of nails, resistance to antifungal drugs, their side effects, and drug interactions limit treatment options. Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser is approved for nail clearance of OM, however conflicting reports exist in literature about its efficacy. This study was conducted to compare the efficacy of Q-switched Nd:YAG laser. AIM: The aim of this study was to find the efficacy of Q-switched Nd:YAG laser (1064 nm) management of OM as monotherapy in comparison to itraconazole. SETTINGS AND DESIGN: A randomized parallel group, outcome assessor trial was conducted over 18 months from July 1, 2015 to December 31, 2016, at skin center of a tertiary care hospital. SUBJECTS AND METHODS: In the first group, patients of OM were administered 12 weekly sessions of the laser. Second group was administered itraconazole 200 mg twice a day for 1 week per month for the 3 months. Confirmed cases of OM, who had not received treatment 6 months before presentation, were selected and randomly allocated to two groups of 50 each. Onychomycosis severity index (OSI) and visual analog scale (VAS) score were used to assess nail involvement at the start of study, 3 months and 1 year after enrollment. STATISTICAL ANALYSIS: Clinical profile of patients was analyzed by chi-square test for qualitative variables. For comparison of quantitative variables, Student t test was performed. A 5% probability level was considered as statistically significant (P < 0.05). RESULTS: VAS and OSI showed statistically significant improvement at 3 and 12 months in Group I, while resulting in faster clearance with laser; OSI was comparable in both groups at 12 months. Mycological cure was significantly higher in Group I. Both dermatophytes as well as non-dermatophytes responded well to laser treatment, whereas non-dermatophytes responded better to laser. CONCLUSIONS: Q-switched Nd:YAG laser is effective in inducing nail clearance in OM and is better than itraconazole in managing non-dermatophyte OM.
format Online
Article
Text
id pubmed-8149989
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-81499892021-06-02 A Study of Q-switched Nd:YAG Laser versus Itraconazole in Management of Onychomycosis Kandpal, Renu Arora, Sandeep Arora, Divya J Cutan Aesthet Surg Original Article CONTEXT: Onychomycosis (OM) accounts for 20%–40% of all nail disorders. Slow growth of nails, resistance to antifungal drugs, their side effects, and drug interactions limit treatment options. Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser is approved for nail clearance of OM, however conflicting reports exist in literature about its efficacy. This study was conducted to compare the efficacy of Q-switched Nd:YAG laser. AIM: The aim of this study was to find the efficacy of Q-switched Nd:YAG laser (1064 nm) management of OM as monotherapy in comparison to itraconazole. SETTINGS AND DESIGN: A randomized parallel group, outcome assessor trial was conducted over 18 months from July 1, 2015 to December 31, 2016, at skin center of a tertiary care hospital. SUBJECTS AND METHODS: In the first group, patients of OM were administered 12 weekly sessions of the laser. Second group was administered itraconazole 200 mg twice a day for 1 week per month for the 3 months. Confirmed cases of OM, who had not received treatment 6 months before presentation, were selected and randomly allocated to two groups of 50 each. Onychomycosis severity index (OSI) and visual analog scale (VAS) score were used to assess nail involvement at the start of study, 3 months and 1 year after enrollment. STATISTICAL ANALYSIS: Clinical profile of patients was analyzed by chi-square test for qualitative variables. For comparison of quantitative variables, Student t test was performed. A 5% probability level was considered as statistically significant (P < 0.05). RESULTS: VAS and OSI showed statistically significant improvement at 3 and 12 months in Group I, while resulting in faster clearance with laser; OSI was comparable in both groups at 12 months. Mycological cure was significantly higher in Group I. Both dermatophytes as well as non-dermatophytes responded well to laser treatment, whereas non-dermatophytes responded better to laser. CONCLUSIONS: Q-switched Nd:YAG laser is effective in inducing nail clearance in OM and is better than itraconazole in managing non-dermatophyte OM. Wolters Kluwer - Medknow 2021 /pmc/articles/PMC8149989/ /pubmed/34084015 http://dx.doi.org/10.4103/JCAS.JCAS_29_20 Text en Copyright: © 2021 Journal of Cutaneous and Aesthetic Surgery https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Kandpal, Renu
Arora, Sandeep
Arora, Divya
A Study of Q-switched Nd:YAG Laser versus Itraconazole in Management of Onychomycosis
title A Study of Q-switched Nd:YAG Laser versus Itraconazole in Management of Onychomycosis
title_full A Study of Q-switched Nd:YAG Laser versus Itraconazole in Management of Onychomycosis
title_fullStr A Study of Q-switched Nd:YAG Laser versus Itraconazole in Management of Onychomycosis
title_full_unstemmed A Study of Q-switched Nd:YAG Laser versus Itraconazole in Management of Onychomycosis
title_short A Study of Q-switched Nd:YAG Laser versus Itraconazole in Management of Onychomycosis
title_sort study of q-switched nd:yag laser versus itraconazole in management of onychomycosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149989/
https://www.ncbi.nlm.nih.gov/pubmed/34084015
http://dx.doi.org/10.4103/JCAS.JCAS_29_20
work_keys_str_mv AT kandpalrenu astudyofqswitchedndyaglaserversusitraconazoleinmanagementofonychomycosis
AT arorasandeep astudyofqswitchedndyaglaserversusitraconazoleinmanagementofonychomycosis
AT aroradivya astudyofqswitchedndyaglaserversusitraconazoleinmanagementofonychomycosis
AT kandpalrenu studyofqswitchedndyaglaserversusitraconazoleinmanagementofonychomycosis
AT arorasandeep studyofqswitchedndyaglaserversusitraconazoleinmanagementofonychomycosis
AT aroradivya studyofqswitchedndyaglaserversusitraconazoleinmanagementofonychomycosis